Nieves Martinez Lago, Specialist in the Field (FEA) of Medical Oncology at University Hospital Complex of Santiago de Compostela, shared on X:
“Early-Onset GI Cancers. A review.
In 2022, CRC led (54%), followed by gastric (24%), esophageal (13%), and pancreatic (9%).
- 15–30% have germline variants
- Prognosis same or worse than later-onset
- Prevention and early detection needed”
More posts Gastric Cancer.